About Acrigen Biosciences

Website
Website
Employees
Employees
1-10 employees View all
Industry
Industry
Biotechnology
Location
Location
1000 Atlantic Ave, Suite 104, Alameda, California 94501, US
Description
Information
Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our proprietary precision gene editing technology. Our technology utilizes novel CRISPR-Cas gene editors coupled with anti-CRISPR proteins to improve the precision, efficacy, and safety of genetic therapies. The company was co-founded in 2019 by Dr. Joseph Bondy-Denomy (Associate Professor at UCSF and discoverer of anti-CRISPR proteins) and Dr. David Rabuka (former Founder and CSO of Redwood Biosciences) with the mission of bringing precision genetic therapies to the clinic.

Acrigen Biosciences Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
Biotechnology

Frequently Asked Questions about Acrigen Biosciences

What is Acrigen Biosciences email format?

The widely used Acrigen Biosciences email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Acrigen Biosciences customer service number?

To contact Acrigen Biosciences customer service number in your country click here to find.


Who is the CEO of Acrigen Biosciences?

David R is the CEO of Acrigen Biosciences. To contact David R email at [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more